Overall rank by patents
#2,857
Across all tracked assignees
USPTO PatentsView assignee record - 134 granted patents across 38 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01Q (SCANNING-PROBE TECHNIQUES OR APPARATUS; APPLICATIONS OF SCANNING-PROBE TECHNIQUES, e.g. SCANNING PROBE MICROSCOPY [SPM]).
The verdict
Bruker holds 134 US patents across 38 technology areas, rank #2,857 of 50,000 tracked assignees.
Bruker Nano, Inc. has been granted 134 US utility patents between 2015 and 2025, placing Bruker Nano, Inc. at rank #2,857 across all assignees tracked by PlainPatent. This portfolio spans 38 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.8 claims per patent with primary concentration in G01Q (SCANNING-PROBE TECHNIQUES OR APPARATUS; APPLICATIONS OF SCANNING-PROBE TECHNIQUES, e.g. SCANNING PROBE MICROSCOPY [SPM]). As a US Corporation, Bruker Nano, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Bruker sits between Second Sight Medical Products, Inc. (135 patents, rank #2,853) and Ingenico Inc. (134 patents, rank #2,861) - the closest US assignees by grant volume. The composite Innovation Score of 58.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 66 grants, compared with 68 in the 2015–2019 window, a -3% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Bruker Nano, Inc.'s 16.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 38 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Bruker Nano, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Second Sight Medical Products, Inc.
135 patents
TAMURA CORPORATION
135 patents
TOAGOSEI CO., LTD.
135 patents
Warner Bros. Entertainment Inc.
135 patents
Hendrickson USA, L.L.C.
134 patents
IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY
134 patents
IMMUNOMEDICS, INC.
134 patents
Ingenico Inc.
134 patents
Bruker Nano, Inc.
134 patents
What this shows Bruker holds 134 patents at rank #2,857, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,857 in granted patent volume.
Other assignees with the most granted patents in Bruker's primary technology class.
Bruker's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
59 Top 4% higher than 96% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 14 | 10.4% |
| 2016 | 15 | 11.2% |
| 2017 | 14 | 10.4% |
| 2018 | 11 | 8.2% |
| 2019 | 14 | 10.4% |
| 2020 | 6 | 4.5% |
| 2021 | 11 | 8.2% |
| 2022 | 16 | 11.9% |
| 2023 | 20 | 14.9% |
| 2024 | 9 | 6.7% |
| 2025 | 4 | 3.0% |
Top 15 of 38 technology areas
Overall rank by patents
#2,857
Across all tracked assignees
58.5 out of 100
How to use this portfolio
Bruker's 134 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.